Mutation of TGFβ-RII eliminates NSAID cancer chemoprevention

Non-steroidal anti-inflammatory drugs (NSAIDs) exhibit anti-neoplastic (chemoprevention) activity for sporadic cancers and the hereditary cancer predisposition Lynch syndrome (LS/HNPCC). However, the mechanism of NSAID tumor suppression has remained enigmatic. Defects in the core mismatch repair (MM...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Martín-López, Juana, Gasparini, Pierluigi, Coombes, Kevin, Croce, Carlo M., Boivin, Gregory P., Fishel, Richard
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2017
Gaiak:
Priority Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5849154/
https://ncbi.nlm.nih.gov/pubmed/29560090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23792
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak